Evidence map›Paper›PMID 21389108›Full record

ArticleMolecular & cellular proteomics : MCP2011

A bioinformatics workflow for variant peptide detection in shotgun proteomics.

Jing Li, Zengliu Su, Ze-Qiang Ma, Robbert J C Slebos, Patrick Halvey, David L Tabb, Daniel C Liebler, William Pao, Bing Zhang

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Empowering Shotgun Mass Spectrometry with 2DE: A HepG2 Study.International journal of molecular sciences · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing LiDepartment of Biomedical Informatics,Vanderbilt University School of Medicine, 2525 West End Ave, Suite 800, Nashville, TN 37232, USA.
Zengliu Su
Ze-Qiang Ma
Robbert J C Slebos
Patrick Halvey
David L Tabb
Daniel C Liebler
William Pao
Bing Zhang

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Clinical Proteomic Technology Assessment for CancerU24CA126479 · NCI · VANDERBILT UNIVERSITY · PI LIEBLER, DANIEL C · 2006 to 2010
$7.9M
New Proteomic Algorithms to Identify Mutant or Modified ProteinsR01CA126218 · NCI · VANDERBILT UNIVERSITY · PI TABB, DAVID L · 2006 to 2010
$1.8M
Systems Approach to the Biological Basis of Colon Cancer MetastasesR01GM088822 · NIGMS · VANDERBILT UNIVERSITY · PI BEAUCHAMP, ROBERT DANIEL, ZHANG, BING · 2009 to 2012
$1.5M
NCI NIH HHS 1U24CA126479NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA126218NCI NIH HHS U24 CA126479NCRR NIH HHS UL1 RR024975NIGMS NIH HHS R01 GM088822
6 · The paper itself

Abstract

Shotgun proteomics data analysis usually relies on database search. However, commonly used protein sequence databases do not contain information on protein variants and thus prevent variant peptides and proteins from been identified. Including known coding variations into protein sequence databases could help alleviate this problem. Based on our recently published human Cancer Proteome Variation Database, we have created a protein sequence database that comprehensively annotates thousands of cancer-related coding variants collected in the Cancer Proteome Variation Database as well as noncancer-specific ones from the Single Nucleotide Polymorphism Database (dbSNP). Using this database, we then developed a data analysis workflow for variant peptide identification in shotgun proteomics. The high risk of false positive variant identifications was addressed by a modified false discovery rate estimation method. Analysis of colorectal cancer cell lines SW480, RKO, and HCT-116 revealed a total of 81 peptides that contain either noncancer-specific or cancer-related variations. Twenty-three out of 26 variants randomly selected from the 81 were confirmed by genomic sequencing. We further applied the workflow on data sets from three individual colorectal tumor specimens. A total of 204 distinct variant peptides were detected, and five carried known cancer-related mutations. Each individual showed a specific pattern of cancer-related mutations, suggesting potential use of this type of information for personalized medicine. Compatibility of the workflow has been tested with four popular database search engines including Sequest, Mascot, X!Tandem, and MyriMatch. In summary, we have developed a workflow that effectively uses existing genomic data to enable variant peptide detection in proteomics.

Indexed as

Computational BiologyAlgorithmsAmino Acid SequenceBase SequenceCarcinomaCell Line, TumorColorectal NeoplasmsDatabases, ProteinGenes, rasHumansMutant ProteinsMutationNeoplasm ProteinsProteomeProteomicsSigmoid NeoplasmsMutant ProteinsNeoplasm ProteinsProteome

Identifiers

PMID21389108
PMCPMC3098595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.